Wellma

Stockholm, Sweden  All Sweden companies → — Founded 2021
Specialty-Focused AI
Private Equity-Backed — unknown

Products

Wellma for Practitioners
Wellma
Clinical Decision Support & Reference
Wellma for Practitioners is an AI co-pilot that extends care plans between sessions, providing real-time client insights, structured follow-up, and pre-session briefs for metabolic health conditions.

See all 1 product →

About Wellma

Wellma is a European company that specializes in the development and manufacturing of nutraceuticals and pharmaceuticals, aiming to be a leading partner for B2C companies in the industry. They achieve this by creating an ecosystem of specialized companies across Europe, each contributing unique capabilities in various product formats such as capsules, tablets, powders, liquids, gummies, gels, bars, and liposomals. This approach allows Wellma to offer a comprehensive range of services, from early-stage formulation and R&D to scale-up, regulatory support, and multi-market production, while maintaining the flexibility and speed typically associated with smaller, specialized players.

Wellma emphasizes quality, innovation, and technology, integrating digital tools and AI to enhance operational efficiency and customer offerings. They partner with credentialed clinicians, acting as an AI co-pilot for metabolic health practitioners. The Wellma platform extends care plans between sessions, providing real-time client insights, structured follow-ups, and AI-drafted pre-session briefs. This allows practitioners to monitor client behavior (meals, mood, movement, adherence) in the 95% of the week they don’t directly observe, leading to more informed sessions and continuous care. The AI features offer personalized nudges, cross-meal pattern detection, and adherence-dip early warnings, all while ensuring HIPAA-ready infrastructure and clinician control, meaning Wellma does not diagnose or prescribe.

Wellma’s commitment to innovation extends to advanced R&D labs and collaborations with universities, focusing on developing complex formulations and leveraging advanced production technology. They also prioritize sustainability, with initiatives linked to the UN’s Sustainable Development Goals. The company’s strategy involves acquiring and integrating entrepreneurial companies that share their values of quality, customer focus, and growth, thereby expanding their geographical reach and capabilities across Europe.

Focus Areas

nutraceutical development and manufacturing pharmaceutical development and manufacturing food supplements contract manufacturing R&D quality control sustainability innovation digital solutions automation robotics capsules tablets powders liquids gummies gels bars liposomals coating granulation pellets

Business Intelligence

Key InvestorsSystematic Growth
PartnershipsVirun NutraBiosciences, Fipros A/S, The Bar Factory, PlantaCorp, NutraResearch, Nutrifundiet, MixMasters, Euronovis
AcquisitionsVirun NutraBiosciences, Fipros A/S, The Bar Factory, PlantaCorp, NutraResearch, Nutrifundiet, MixMasters, Euronovis
TechnologyAI, robotics, advanced digital solutions, proprietary online configurator
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

Nutraceutical & Pharmaceutical Development and Manufacturing
Wellma specializes in the high-quality production of food supplements, nutraceuticals, and pharmaceuticals. They offer end-to-end services from idea and formulation to production, packaging, and regulatory support. Their capabilities span a wide range of formats including capsules, tablets, powders, liquids, softgels, gummies, gels, bars, liposomals, coating, granulation, and pellets.
Advanced R&D and Innovation
Wellma has a Global R&D Center in Barcelona and specialized labs at each site, focusing on developing innovative products with a competitive edge. They proactively explore new ingredients, technologies, and delivery systems, including advanced lipid carrier technology for enhanced bioavailability (e.g., liposomal encapsulation). Wellma also collaborates with universities for academic research.
Comprehensive Quality Control
Quality is central to Wellma's operations, with a 'Quality Promise' that sets high standards for all sites, personnel, and suppliers. All production sites operate under internationally recognized GFSI-approved food safety standards (e.g., BRC, FSSC 22000, IFS) and cGMP for pharmaceuticals. They conduct rigorous internal and external audits, and extensive testing on raw materials, in-process samples, and finished products using advanced equipment.
Sustainability and ESG Commitment
Wellma is committed to ESG principles through its 'Wellma x LIFE' initiative, built around four pillars: lasting impact on people's health, integrity in operations, fulfilling their people promise, and environmental responsibility. These pillars are aligned with the UN's Sustainable Development Goals. They also focus on sustainable packaging solutions, such as blister packaging designed to replace traditional non-recyclable formats.
Digital Solutions and Automation
Wellma integrates digital technology to enhance operational efficiency, with in-house software developers creating custom solutions for more efficient processes. They leverage automation and robotics in their production technologies, particularly in specialized areas like powders and gels. Wellma also offers an AI co-pilot for metabolic health practitioners, which translates care plans into daily micro-actions, real-time nudges, and instant feedback for clients.
Broad Product Formats and Delivery Systems
Wellma offers a comprehensive range of product formats, including capsules, tablets, powders, liquids, gummies, gels, bars, and liposomals. They specialize in advanced delivery systems like liposomal encapsulation and emulsions to enhance bioavailability and nutrient absorption.
Physician Tip

For physicians, Wellma stands out due to its relentless focus on quality and regulatory compliance, ensuring that products meet the highest standards and are safe for patient consumption. Their advanced R&D capabilities, including expertise in enhancing absorption and bioavailability through technologies like liposomal encapsulation, are crucial for developing effective nutraceutical and pharmaceutical interventions. The company's ability to offer a wide range of formats and custom formulations allows for tailored solutions to specific patient needs. Furthermore, Wellma's commitment to innovation and scientific partnerships means they are at the forefront of developing next-generation supplements. The AI co-pilot for metabolic health practitioners can be a valuable tool for continuous patient engagement, monitoring adherence, and gaining insights into patient patterns between sessions, ultimately leading to more informed clinical decisions and improved patient outcomes.

Wellma's digital solutions include an AI co-pilot designed for metabolic health practitioners. This platform can integrate existing meal plans, lifestyle protocols, or clinical programs, delivering them as daily micro-actions to clients via WhatsApp or in-app. The AI learns from client interactions (meal photos, check-ins, journal entries) to provide personalized feedback and pre-session summaries for practitioners. The system is built with HIPAA-ready infrastructure, ensuring client data privacy and security. This suggests potential for integration with existing practice management systems or electronic health records to streamline patient care and data flow, though specific API details are not provided.

Products by Wellma

1 product in the directory

Wellma for Practitioners
Wellma
Clinical Decision Support & Reference
Wellma for Practitioners is an AI co-pilot that extends care plans between sessions, providing real-time client insights, structured follow-up, and pre-session briefs for metabolic health conditions.

What the Web Says

Wellma (wellma.com) appears to be a healthcare technology company, but specific product and employer reviews from major platforms like G2, Glassdoor, and Capterra, as well as Reddit and dedicated healthcare IT reviewers, are not readily available or easily discoverable through a general web search. Information regarding their offerings and internal company culture is limited in public reviews.

Overall: Mixed

Strengths

  • Information not readily available in public reviews.
  • Unknown
  • Unknown
  • Unknown
  • Unknown
  • Unknown

Limitations

  • Lack of readily available public reviews on major platforms (G2, Glassdoor, Capterra).
  • Limited public information regarding product features and user experience.
  • Limited public information regarding company culture and employee experience.
  • Difficulty in assessing overall sentiment due to lack of reviews.
  • Unknown
  • Unknown

Based on reviews from: G2 (no specific reviews found), Glassdoor (no specific reviews found), Capterra (no specific reviews found), Healthcare IT reviewers (no specific reviews found), Reddit (no specific discussions found)

Last updated: 2026-09-21

Videos

News, demos, and interviews about Wellma.

Loading videos...

Videos load interactively. If none appear, search YouTube for Wellma →

View all on YouTube

Press & Coverage

Wellma
Wellma welcomes Virun to its family
Wellma announced on July 13, 2026, that it has welcomed Virun NutraBiosciences to its family, establishing Wellma's first US and Ireland sites and bringing advanced lipid delivery systems.
2026-07
NutraIngredients.com
Fast-growing CDMO Wellma acquires Virun NutraBiosciences
Wellma, a rapidly expanding global leader in nutraceutical development and co-manufacturing, has acquired Virun NutraBiosciences, marking its thirteenth acquisition and first in the U.S.
2026-07
Wellma
Wellma joins forces with Mondial Pack
In January 2026, Wellma partnered with Mondial Pack, a leading CDMO in capsules and softgels based in the Netherlands, aiming to enhance customer value through a focus on quality, flexibility, and speed.
2026-01
Wellma
Wellma joins Forces with PlantaCorp, pioneering CDMO in Liposomal Technology R&D and production
Wellma announced a strategic partnership with PlantaCorp, a German CDMO specializing in liposomal technology for liquid formulations, on April 7, 2025, to enhance bioavailability of active ingredients.
2025-04
Crowe
Crowe advises Wellma on merger with PlantaCorp
Crowe BPG advised Wellma on its merger with PlantaCorp, a German contract manufacturer of liposomal nutritional supplements, strengthening Wellma's position in the food supplement and pharmaceutical industry.
2025-04
Wellma
Wellma joins forces with NutraResearch, a leading nutraceutical CDMO and R&D center
On January 29, 2025, Wellma announced a strategic partnership with NutraResearch, a Barcelona-based CDMO and R&D center specializing in liquid and solid nutraceutical products.
2025-01
Cuatrecasas
Wellma's strategic partnerships with Nutrifundiet and Nutraresearch to strengthen position in Europe
Cuatrecasas advised Wellma on its strategic partnerships with Nutrifundiet and NutraResearch in February 2025, aiming to boost innovation and strengthen Wellma's European market position in nutraceuticals and pharmaceuticals.
2025-02
Wellma
Wellma joins forces with CDMO Nutrifundiet specialized in nutraceutical gummies
Wellma announced a strategic partnership with Nutrifundiet, a specialized developer and manufacturer of nutraceutical gummies, on January 24, 2025, marking Wellma's entry into the high-growth gummy sector.
2025-01

Frequently Asked Questions

Wellma offers comprehensive development and manufacturing services for nutraceuticals and pharmaceuticals, covering a wide array of formats including capsules, tablets, powders, liquids, gummies, gels, bars, and liposomals. They provide end-to-end support from early-stage formulation and R&D to scale-up, regulatory assistance, and multi-market production.
Wellma maintains a relentless focus on quality, with all production sites operating under internationally recognized GFSI-approved food safety standards such as BRC, FSSC 22000, and IFS. For pharmaceuticals, sites are also cGMP certified. They implement strict internal audits, robust quality systems, and continuous improvement processes, extending to consistent audits of all suppliers.
Wellma emphasizes innovation through its Global R&D Center in Barcelona, specialized labs, advanced technology platforms, and scientific partnerships. Each production site has dedicated development teams with format-specific expertise, and they proactively explore new ingredients, technologies, and delivery systems to help customers stay ahead of trends.
Yes, Wellma has full-range capabilities across all major supplement formats, including specialized delivery systems. They have deep, format-specific expertise, with individual development and production sites dedicated to a single format, such as their Hamburg site specializing in liposomal formulations for enhanced bioavailability.
Wellma is committed to ESG (Environmental, Social, and Governance) principles through its 'Wellma x LIFE' initiative, which aligns with the UN's Sustainable Development Goals. This commitment includes initiatives for lasting impact on health and wellness, integrity in operations, fulfilling their people promise, and environmental responsibility towards a sustainable planet.
Wellma integrates digital technology to enhance operational efficiency, with in-house software developers creating custom solutions for more efficient processes, such as minimizing quote times. They also incorporate advanced production technology, automation, and robotics to bring complex solutions to market and serve intricate formulations in various formats.
Wellma strategically partners with entrepreneurial companies that have unique capabilities, creating an ecosystem of specialists across Europe. These partnerships, such as with PlantaCorp for liposomal technology, NutraResearch for R&D, and The Bar Factory for functional bars, expand Wellma's product range, geographical reach, and specialized expertise, contributing to their growth and stability as a European leader in nutraceutical and pharmaceutical development and production.

Investors

Who's funded Wellma.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.